RTB101 (Dactolisib analog, TORC1 / TORC2 inhibitor) — Research Compounds Library | RetatrutideCompare

Dual TORC1/2 inhibitor evaluated for prevention of respiratory tract infection in older adults. PROTECTOR phase 3 trial (2020) missed its primary endpoint.